Home Depot (HD) investors got a scare Monday following a downgrade from analysts at Piper Jaffray. Nevertheless, Tom Anderson, chief investment officer at Boston Private, said there is no reason to be spooked by the retailer's shares and the Halloween selloff should be viewed as a treat rather than a trick. Anderson is also bullish on Celgene (CELG) which saw its shares surge last week after the biotech posted higher-than-anticipated results for the 2016 third quarter and increased its forecast for the full year. Charles Schwab (SCHW) is another one of Anderson's top picks. "Schwab is a high quality brand that will perform even better when interest rates move up," said Anderson. Finally, Anderson is a fan of Allergan (AGN) , despite the company's third quarter earnings miss on Wednesday. Anderson believes the Botox-seller will rebound in 2017.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.